Weight loss jabs containing semaglutide, the main ingredient in medications like Wegovy and Ozempic, have been linked to potential risks for women seeking to conceive. Experts warn against using these jabs during pregnancy, as their effects on pregnant women and their babies remain unknown. Animal studies have raised concerns about toxicity, miscarriage, and birth abnormalities associated with semaglutide. Women planning to become pregnant are advised to stop taking weight loss jabs two months prior to conception. Research suggests that weight loss in general can enhance fertility, particularly for individuals with polycystic ovary syndrome (PCOS). However, the impact of semaglutide specifically on pregnancy outcomes requires further investigation. Healthcare professionals emphasize the importance of using contraception while taking weight loss jabs and ceasing use well in advance of attempting to conceive. As weight loss jabs become more prevalent, particularly in the US, women considering their use for fertility purposes should seek medical guidance and be fully informed of the potential risks and uncertainties associated with their application during pregnancy and infertility treatment.
Weight Loss Jabs: Potential Risks for Pregnancy and Fertility
dev
